David P. King is the executive chairman of LabCorp, retiring in 2019 as president and CEO after nearly two decades at the company, including almost 13 years as CEO. In his role as executive chairman, King continues to serve the company as a leader who operates with a strong emphasis on deeply understanding the healthcare industry, strategic planning, “playing the long game,” and staying ahead of rapidly evolving industry trends and challenges.
Prior to becoming CEO on Jan. 1, 2007, King served as LabCorp’s executive vice president and chief operating officer and as executive vice president of strategic planning and corporate development. King joined LabCorp as senior vice president, general counsel, and chief compliance officer in 2001 after serving for several years as the company’s principal outside legal counsel. Before joining LabCorp, he practiced law in Baltimore, first as an Assistant United States Attorney, then in private practice with Hogan & Hartson LLP (now Hogan Lovells).
King is the board chair of PATH, a nonprofit global health organization, and was appointed in 2017 to the advisory board for Duke University’s Robert J. Margolis, MD, Center for Health Policy. In addition, he serves on the boards of Elon University in Elon, North Carolina, and the American Clinical Laboratory Association (ACLA), where he served as chair from 2010 to 2014. King holds an AB degree, cum laude, from Princeton University and a JD degree, cum laude, from the University of Pennsylvania Law School.